"The IDE Approval is beneficial in supporting our ongoing CE mark application and we remain confident of obtaining our CE Mark in the near term. Our clinical team continues to advance the engagement with leading clinicians and centres in Europe, with the aim of treating both Study subjects and commercial cases, once we achieve our CE mark."
- Forums
- ASX - By Stock
- Ann: FDA IDE Approval-OSL.AX
OSL
oncosil medical ltd
Add to My Watchlist
0.00%
!
$1.23

"The IDE Approval is beneficial in supporting our ongoing CE...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.000(0.00%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3591 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.24 | 800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3591 | 1.250 |
2 | 15 | 1.230 |
1 | 1323 | 1.200 |
1 | 3500 | 1.190 |
1 | 90 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.240 | 800 | 1 |
1.250 | 60000 | 1 |
1.500 | 15 | 1 |
1.600 | 19150 | 1 |
0.000 | 0 | 0 |
Last trade - 09.22am 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online